A care pathway for the cardiovascular complications of COVID-19: Insights from an institutional response - 19/06/20
, Michael R. Rehorn, MD, MS, L. Kristin Newby, MD, MHS, Jason N. Katz, MD, MHS, Igor Klem, MD, Robert J. Mentz, MD, W. Schuyler Jones, MD, Sreekanth Vemulapalli, MD, Anita M. Kelsey, MD, Michael A. Blazing, MD, Jonathan P. Piccini, MD, MHS, Manesh R. Patel, MD
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Abstract |
The infection caused by severe acute respiratory syndrome coronavirus-2, or COVID-19, can result in myocardial injury, heart failure, and arrhythmias. In addition to the viral infection itself, investigational therapies for the infection can interact with the cardiovascular system. As cardiologists and cardiovascular service lines will be heavily involved in the care of patients with COVID-19, our division organized an approach to manage these complications, attempting to balance resource utilization and risk to personnel with optimal cardiovascular care. The model presented can provide a framework for other institutions to organize their own approaches and can be adapted to local constraints, resource availability, and emerging knowledge.
Il testo completo di questo articolo è disponibile in PDF.Mappa
| Timothy D. Henry, MD, served as guest editor for this article. |
|
| Funding: No extramural funding was used to support this work. |
Vol 225
P. 3-9 - luglio 2020 Ritorno al numero
Articolo precedente
- The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation
- Ganesan Karthikeyan, Stuart J Connolly, Mpiko Ntsekhe, Alexander Benz, Sumathy Rangarajan, Gayle Lewis, Yan Yun, Sanjib Kumar Sharma, Fathi Maklady, Alaa Eldin Elghamrawy, Khawar Kazmi, Tantchou T J Cabral, Hu Dayi, Ma Changsheng, Bernard M Gitura, Alvaro Avezum, Liesl Zuhlke, Peter Lwabi, Abraham Haileamlak, Okechukwu Ogah, Pilly Chillo, Maria Paniagua, Ahmed ElSayed, Antonio Dans, Lillian Gondwe-Chunda, Onkabetse Julia Molefe-Baikai, Jesus A Gonzalez-Hermosillo, James Hakim, Albertino Damasceno, Emmanuel R Kamanzi, John Musuku, Kairat Davletov, Katherine Connolly, Bongani M Mayosi, Salim Yusuf, INVICTUS Investigators
- Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trial
- Paul Guedeney, Holger Thiele, Mathieu Kerneis, Olivier Barthélémy, Stefan Baumann, Marcus Sandri, Suzanne de Waha-Thiele, Georg Fuernau, Stéphanie Rouanet, Jan J. Piek, Ulf Landmesser, Marie Hauguel-Moreau, Michel Zeitouni, Johanne Silvain, Benoit Lattuca, Stephan Windecker, Jean-Philippe Collet, Steffen Desch, Uwe Zeymer, Gilles Montalescot, Ibrahim Akin, CULPRIT-SHOCK Investigators
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.